There is a little known company that is changing warfare

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

Judy Joice Biography and Net Worth

VP of DURECT

Judy Joice, Senior Vice President, Operations and Corporate Quality Assurance, joined DURECT in 2007 and has over 25 years experience in the pharmaceutical industry with such companies as Nektar Therapeutics, Oread and Syntex Research. During her career, Ms. Joice has gained broad experience in developing, implementing and managing all aspects of company-wide quality systems and compliance functions, ranging from drug development through commercial manufacturing. Ms. Joice has a B.S. in Chemistry from California State University.

What is Judy R. Joice's net worth?: The estimated net worth of Judy R. Joice is at least $55,380.32 as of May 14th, 2021. Ms. Joice owns 54,832 shares of DURECT stock worth more than $55,380 as of November 17th. This net worth estimate does not reflect any other assets that Ms. Joice may own. Additionally, Ms. Joice receives an annual salary of $451,820.00 as VP at DURECT. Learn More about Judy R. Joice's net worth.
How old is Judy R. Joice?: Ms. Joice is currently 67 years old. There are 4 older executives and no younger executives at DURECT. The oldest executive at DURECT is Dr. Su Il Yum Ph.D., Executive Officer, who is 85 years old. Learn More on Judy R. Joice's age.
What is Judy R. Joice's salary?: As the VP of DURECT Co., Ms. Joice earns $451,820.00 per year. There are 2 executives that earn more than Ms. Joice. The highest earning executive at DURECT is Dr. James E. Brown D.V.M., Co-Founder, CEO, President & Director, who commands a salary of $633,460.00 per year. Learn More on Judy R. Joice's salary.
How do I contact Judy R. Joice?: The corporate mailing address for Ms. Joice and other DURECT executives is 10260 BUBB RD, CUPERTINO CA, 95014. DURECT can also be reached via phone at (408) 777-1417 and via email at [email protected]. Learn More on Judy R. Joice's contact information.
Has Judy R. Joice been buying or selling shares of DURECT?: Judy R. Joice has not been actively trading shares of DURECT during the past quarter. Most recently, Judy R. Joice sold 60,137 shares of the business's stock in a transaction on Friday, May 14th. The shares were sold at an average price of $1.72, for a transaction totalling $103,435.64. Following the completion of the sale, the vice president now directly owns 54,832 shares of the company's stock, valued at $94,311.04. Learn More on Judy R. Joice's trading history.
Who are DURECT's active insiders?: DURECT's insider roster includes Simon Benito (Director), and Judy Joice (VP). Learn More on DURECT's active insiders.

Judy R. Joice Insider Trading History at DURECT

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/14/2021	Sell	60,137	$1.72	$103,435.64	54,832
6/3/2020	Sell	57,820	$2.45	$141,659.00	67,611

Judy R. Joice Buying and Selling Activity at DURECT

DURECT Company Overview

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.

Today's Range

Now: $1.01

$1.00

$1.18

50 Day Range

MA: $1.35

$1.01

$1.57

2 Week Range

Now: $1.01

$0.48

$1.88

Volume

126,394 shs

Average Volume

66,395 shs

Market Capitalization

$31.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13

There is a little known company that is changing warfare

From Reticulate | Ad